|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:GALNT11-PTPRN2 (FusionGDB2 ID:32123) |
Fusion Gene Summary for GALNT11-PTPRN2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: GALNT11-PTPRN2 | Fusion gene ID: 32123 | Hgene | Tgene | Gene symbol | GALNT11 | PTPRN2 | Gene ID | 63917 | 5799 |
Gene name | polypeptide N-acetylgalactosaminyltransferase 11 | protein tyrosine phosphatase receptor type N2 | |
Synonyms | GALNAC-T11|GALNACT11 | IA-2beta|IAR|ICAAR|PTPRP|R-PTP-N2 | |
Cytomap | 7q36.1|7q36.1 | 7q36.3 | |
Type of gene | protein-coding | protein-coding | |
Description | polypeptide N-acetylgalactosaminyltransferase 11UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11)polypeptide GalNAc transferase 11pp-GaNTase 11p | receptor-type tyrosine-protein phosphatase N2IAR/receptor-like protein-tyrosine phosphataseislet cell autoantigen-related proteinphogrinprotein tyrosine phosphatase receptor piprotein tyrosine phosphatase, receptor type, N polypeptide 2tyrosine phos | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000482812, ENST00000430044, ENST00000452146, ENST00000434507, ENST00000415421, ENST00000320311, ENST00000422997, | ENST00000389413, ENST00000409483, ENST00000389416, ENST00000389418, ENST00000404321, | |
Fusion gene scores | * DoF score | 14 X 8 X 9=1008 | 16 X 17 X 9=2448 |
# samples | 16 | 24 | |
** MAII score | log2(16/1008*10)=-2.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(24/2448*10)=-3.35049724708413 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: GALNT11 [Title/Abstract] AND PTPRN2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | GALNT11(151722969)-PTPRN2(158282477), # samples:3 PTPRN2(157959623)-GALNT11(151797883), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GALNT11 | GO:0018243 | protein O-linked glycosylation via threonine | 24226769 |
Fusion gene breakpoints across GALNT11 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PTPRN2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-X6-A8C4-01A | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
ChimerDB4 | SARC | TCGA-X6-A8C4-01A | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
ChimerDB4 | SARC | TCGA-X6-A8C4-01A | GALNT11 | chr7 | 151722969 | - | PTPRN2 | chr7 | 158282477 | - |
Top |
Fusion Gene ORF analysis for GALNT11-PTPRN2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000482812 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
3UTR-3CDS | ENST00000482812 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
3UTR-intron | ENST00000482812 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
3UTR-intron | ENST00000482812 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
3UTR-intron | ENST00000482812 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5UTR-3CDS | ENST00000430044 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5UTR-3CDS | ENST00000430044 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5UTR-intron | ENST00000430044 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5UTR-intron | ENST00000430044 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5UTR-intron | ENST00000430044 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
In-frame | ENST00000452146 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
In-frame | ENST00000452146 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5CDS-intron | ENST00000452146 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5CDS-intron | ENST00000452146 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
5CDS-intron | ENST00000452146 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000434507 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000434507 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000434507 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000434507 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000434507 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000415421 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000415421 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000415421 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000415421 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000415421 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000320311 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000320311 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000320311 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000320311 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000320311 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000422997 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-3CDS | ENST00000422997 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000422997 | ENST00000389416 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000422997 | ENST00000389418 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
intron-intron | ENST00000422997 | ENST00000404321 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000452146 | GALNT11 | chr7 | 151722969 | + | ENST00000389413 | PTPRN2 | chr7 | 158282477 | - | 4641 | 134 | 7 | 2982 | 991 |
ENST00000452146 | GALNT11 | chr7 | 151722969 | + | ENST00000409483 | PTPRN2 | chr7 | 158282477 | - | 4614 | 134 | 7 | 2955 | 982 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000452146 | ENST00000389413 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - | 0.002278918 | 0.997721 |
ENST00000452146 | ENST00000409483 | GALNT11 | chr7 | 151722969 | + | PTPRN2 | chr7 | 158282477 | - | 0.002590065 | 0.99741 |
Top |
Fusion Genomic Features for GALNT11-PTPRN2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for GALNT11-PTPRN2 |
Go to FGviewer for the breakpoints of chr7:151722969-chr7:158282477 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 745_1005 | 37.333333333333336 | 987.0 | Domain | Tyrosine-protein phosphatase | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 745_1005 | 0 | 999.0 | Domain | Tyrosine-protein phosphatase | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 745_1005 | 37.333333333333336 | 1016.0 | Domain | Tyrosine-protein phosphatase | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 745_1005 | 60.333333333333336 | 1039.0 | Domain | Tyrosine-protein phosphatase | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 1004_1010 | 37.333333333333336 | 987.0 | Motif | Leucine-based sorting signal | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 666_675 | 37.333333333333336 | 987.0 | Motif | Tyrosine-based internalization motif | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 1004_1010 | 0 | 999.0 | Motif | Leucine-based sorting signal | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 666_675 | 0 | 999.0 | Motif | Tyrosine-based internalization motif | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 1004_1010 | 37.333333333333336 | 1016.0 | Motif | Leucine-based sorting signal | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 666_675 | 37.333333333333336 | 1016.0 | Motif | Tyrosine-based internalization motif | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 1004_1010 | 60.333333333333336 | 1039.0 | Motif | Leucine-based sorting signal | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 666_675 | 60.333333333333336 | 1039.0 | Motif | Tyrosine-based internalization motif | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 945_951 | 37.333333333333336 | 987.0 | Region | Substrate binding | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 945_951 | 0 | 999.0 | Region | Substrate binding | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 945_951 | 37.333333333333336 | 1016.0 | Region | Substrate binding | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 945_951 | 60.333333333333336 | 1039.0 | Region | Substrate binding | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 637_1015 | 37.333333333333336 | 987.0 | Topological domain | Cytoplasmic | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 22_615 | 0 | 999.0 | Topological domain | Extracellular | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 637_1015 | 0 | 999.0 | Topological domain | Cytoplasmic | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 637_1015 | 37.333333333333336 | 1016.0 | Topological domain | Cytoplasmic | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 637_1015 | 60.333333333333336 | 1039.0 | Topological domain | Cytoplasmic | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 616_636 | 37.333333333333336 | 987.0 | Transmembrane | Helical | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389416 | 0 | 22 | 616_636 | 0 | 999.0 | Transmembrane | Helical | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 616_636 | 37.333333333333336 | 1016.0 | Transmembrane | Helical | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 616_636 | 60.333333333333336 | 1039.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 476_607 | 0 | 609.0 | Domain | Ricin B-type lectin |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 476_607 | 0 | 203.0 | Domain | Ricin B-type lectin |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 476_607 | 0 | 609.0 | Domain | Ricin B-type lectin |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 476_607 | 0 | 609.0 | Domain | Ricin B-type lectin |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 150_261 | 0 | 609.0 | Region | Note=Catalytic subdomain A |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 319_381 | 0 | 609.0 | Region | Note=Catalytic subdomain B |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 150_261 | 0 | 203.0 | Region | Note=Catalytic subdomain A |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 319_381 | 0 | 203.0 | Region | Note=Catalytic subdomain B |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 150_261 | 0 | 609.0 | Region | Note=Catalytic subdomain A |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 319_381 | 0 | 609.0 | Region | Note=Catalytic subdomain B |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 150_261 | 0 | 609.0 | Region | Note=Catalytic subdomain A |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 319_381 | 0 | 609.0 | Region | Note=Catalytic subdomain B |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 1_6 | 0 | 609.0 | Topological domain | Cytoplasmic |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 30_608 | 0 | 609.0 | Topological domain | Lumenal |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 1_6 | 0 | 203.0 | Topological domain | Cytoplasmic |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 30_608 | 0 | 203.0 | Topological domain | Lumenal |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 1_6 | 0 | 609.0 | Topological domain | Cytoplasmic |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 30_608 | 0 | 609.0 | Topological domain | Lumenal |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 1_6 | 0 | 609.0 | Topological domain | Cytoplasmic |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 30_608 | 0 | 609.0 | Topological domain | Lumenal |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000320311 | + | 1 | 12 | 7_29 | 0 | 609.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000415421 | + | 1 | 5 | 7_29 | 0 | 203.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000430044 | + | 1 | 12 | 7_29 | 0 | 609.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | GALNT11 | chr7:151722969 | chr7:158282477 | ENST00000434507 | + | 1 | 14 | 7_29 | 0 | 609.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389413 | 0 | 22 | 22_615 | 37.333333333333336 | 987.0 | Topological domain | Extracellular | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000389418 | 0 | 23 | 22_615 | 37.333333333333336 | 1016.0 | Topological domain | Extracellular | |
Tgene | PTPRN2 | chr7:151722969 | chr7:158282477 | ENST00000404321 | 0 | 23 | 22_615 | 60.333333333333336 | 1039.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for GALNT11-PTPRN2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000452146_ENST00000389413_TCGA-X6-A8C4-01A_GALNT11_chr7_151722969_+_PTPRN2_chr7_158282477_length(transcript)=4641nt_BP=134nt GCGACGCCTGGCTGCTGGGCCCCGGGGCAGTTCAGCCCGCGCCGCTCCTGCGGGTCGGACTGGGGCTGTGGCGGGAGAGAAGATGCCGCA GCCCGAGTCCCAGAAGGCGGCGATCCTGGGCTGCGGGCAAGGCGGCTGCCTGCTCGAGGAGGGCCTCTGCGGAGCGTCCGAGGCCTGTGT GAACGATGGAGTGTTTGGAAGGTGCCAGAAGGTTCCGGCAATGGACTTTTACCGCTACGAGGTGTCGCCCGTGGCCCTGCAGCGCCTGCG CGTGGCGTTGCAGAAGCTTTCCGGCACAGGTTTCACGTGGCAGGATGACTATACTCAGTATGTGATGGACCAGGAACTTGCAGACCTCCC GAAAACCTACCTGAGGCGTCCTGAAGCATCCAGCCCAGCCAGGCCCTCAAAACACAGCGTTGGCAGCGAGAGGAGGTACAGTCGGGAGGG CGGTGCTGCCCTGGCCAACGCCCTCCGACGCCACCTGCCCTTCCTGGAGGCCCTGTCCCAGGCCCCAGCCTCAGACGTGCTCGCCAGGAC CCATACGGCGCAGGACAGACCCCCCGCTGAGGGTGATGACCGCTTCTCCGAGAGCATCCTGACCTATGTGGCCCACACGTCTGCGCTGAC CTACCCTCCCGGGTCCCGGACCCAGCTCCGCGAGGACCTCCTGCCGCGGACCCTCGGCCAGCTCCAGCCAGATGAGCTCAGCCCTAAGGT GGACAGTGGTGTGGACAGACACCATCTGATGGCGGCCCTCAGTGCCTATGCTGCCCAGAGGCCCCCAGCTCCCCCCGGGGAGGGCAGCCT GGAGCCACAGTACCTTCTGCGTGCACCCTCAAGAATGCCCAGGCCTTTGCTGGCACCAGCCGCCCCCCAGAAGTGGCCTTCACCTCTGGG AGATTCCGAAGACCCCTCCAGCACAGGCGATGGAGCACGGATTCATACCCTCCTGAAGGACCTGCAGAGGCAGCCGGCTGAGGTGAGGGG CCTGAGTGGCCTGGAGCTGGACGGCATGGCTGAGCTGATGGCTGGCCTGATGCAAGGCGTGGACCATGGAGTAGCTCGAGGCAGCCCTGG GAGAGCGGCCCTGGGAGAGTCTGGAGAACAGGCGGATGGCCCCAAGGCCACCCTCCGTGGAGACAGCTTTCCAGATGACGGAGTGCAGGA CGACGATGATAGACTTTACCAAGAGGTCCATCGTCTGAGTGCCACACTCGGGGGCCTCCTGCAGGACCACGGGTCTCGACTCTTACCTGG AGCCCTCCCCTTTGCAAGGCCCCTCGACATGGAGAGGAAGAAGTCCGAGCACCCTGAGTCTTCCCTGTCTTCAGAAGAGGAGACTGCCGG AGTGGAGAACGTCAAGAGCCAGACGTATTCCAAAGATCTGCTGGGGCAGCAGCCGCATTCGGAGCCCGGGGCCGCTGCGTTTGGGGAGCT CCAAAACCAGATGCCTGGGCCCTCGAAGGAGGAGCAGAGCCTTCCAGCGGGTGCTCAGGAGGCCCTCAGCGACGGCCTGCAATTGGAGGT CCAGCCTTCCGAGGAAGAGGCGCGGGGCTACATCGTGACAGACAGAGAGGTTCTCGGACCAGCAGTGACCTTCAAAGTGAGCGCCAATGT CCAAAACGTGACCACTGAGGATGTGGAGAAGGCCACAGTTGACAACAAAGACAAACTGGAGGAAACCTCTGGACTGAAAATTCTTCAAAC CGGAGTCGGGTCGAAAAGCAAACTCAAGTTCCTGCCTCCTCAGGCGGAGCAAGAAGACTCCACCAAGTTCATCGCGCTCACCCTGGTCTC CCTCGCCTGCATCCTGGGCGTCCTCCTGGCCTCTGGCCTCATCTACTGCCTCCGCCATAGCTCTCAGCACAGGCTGAAGGAGAAGCTCTC GGGACTAGGGGGCGACCCAGGTGCAGATGCCACTGCCGCCTACCAGGAGCTGTGCCGCCAGCGTATGGCCACGCGGCCACCAGACCGACC TGAGGGCCCGCACACGTCACGCATCAGCAGCGTCTCATCCCAGTTCAGCGACGGGCCGATCCCCAGCCCCTCCGCACGCAGCAGCGCCTC ATCCTGGTCCGAGGAGCCTGTGCAGTCCAACATGGACATCTCCACCGGCCACATGATCCTGTCCTACATGGAGGACCACCTGAAGAACAA GAACCGGCTGGAGAAGGAGTGGGAAGCGCTGTGCGCCTACCAGGCGGAGCCCAACAGCTCGTTCGTGGCCCAGAGGGAGGAGAACGTGCC CAAGAACCGCTCCCTGGCCGTGCTGACCTATGACCACTCCCGGGTCCTGCTGAAGGCGGAGAACAGCCACAGCCACTCAGACTACATCAA CGCTAGCCCCATCATGGATCACGACCCGAGGAACCCCGCGTACATCGCCACCCAGGGACCGCTGCCCGCCACCGTGGCTGACTTTTGGCA GATGGTGTGGGAGAGCGGCTGCGTGGTGATCGTCATGCTGACACCCCTCGCGGAGAACGGCGTCCGGCAGTGCTACCACTACTGGCCGGA TGAAGGCTCCAATCTCTACCACATCTATGAGGTGAACCTGGTCTCCGAGCACATCTGGTGTGAGGACTTCCTGGTGAGGAGCTTCTATCT GAAGAACCTGCAGACCAACGAGACGCGCACCGTGACGCAGTTCCACTTCCTGAGTTGGTATGACCGAGGAGTCCCTTCCTCCTCAAGGTC CCTCCTGGACTTCCGCAGAAAAGTAAACAAGTGCTACAGGGGCCGTTCTTGTCCAATAATTGTTCATTGCAGTGACGGTGCAGGCCGGAG CGGCACCTACGTCCTGATCGACATGGTTCTCAACAAGATGGCCAAAGGTGCTAAAGAGATTGATATCGCAGCGACCCTGGAGCACTTGAG GGACCAGAGACCCGGCATGGTCCAGACGAAGGAGCAGTTTGAGTTCGCGCTGACAGCCGTGGCTGAGGAGGTGAACGCCATCCTCAAGGC CCTTCCCCAGTGAGCGGCAGCCTCAGGGGCCTCAGGGGAGCCCCCACCCCACGGATGTTGTCAGGAATCATGATCTGACTTTAATTGTGT GTCTTCTATTATAACTGCATAGTAATAGGGCCCTTAGCTCTCCCGTAGTCAGCGCAGTTTAGCAGTTAAAAGTGTATTTTTGTTTAATCA AACAATAATAAAGAGAGATTTGTGGAAAAATCCAGTTACGGGTGGAGGGGAATCGGTTCATCAATTTTCACTTGCTTAAAAAAAATACTT TTTCTTAAAGCACCCGTTCACCTTCTTGGTTGAAGTTGTGTTAACAATGCAGTAGCCAGCACGTTCGAGGCGGTTTCCAGGAAGAGTGTG CTTGTCATCTGCCACTTTCGGGAGGGTGGATCCACTGTGCAGGAGTGGCCGGGGAAGCTGGCAGCACTCAGTGAGGCCGCCCGGCACACA AGGCACGTTTGGCATTTCTCTTTGAGAGAGTTTATCATTGGGAGAAGCCGCAGGGACAGAACTGAACGTCCTGCAGCTTCGGGGCAAGTG AGACAATCACAGCTCCTCGCTGCGTCTCCATCAACACTGCGCCGGGTACCATGGACGGCCCCGTCAGCCACACCTGTCAGCCCAAGCAGA GTGATTCAGGGGCTCCCCGGGGGCAGACACCTGTGCACCCCATGAGTAGTGCCCACTTGAGGCTGGCACTCCCCTGACCTCACCTTTGCA AAGTTACAGATGCACCCCAACATTGAGATGTGTTTTTAATGTTAAAATATTGATTTCTACGTTATGAAAACAGATGCCCCCGTGAATGCT TACCTGTGAGATAACCACAACCAGGAAGAACAAATCTGGGCATTGAGCAAGCTATGAGGGTCCCCGGGAGCACACGAACCCTGCCAGGCC CCCGCTGGCTCCTCCAGGCACGTCCCGGACCTGTGGGGCCCCAGAGAGGGGACATTTCCCTCCTGGGAGAGAAGGAGATCAGGGCAACTC GGAGAGGGCTGCGAGCATTTCCCTCCCGGGAGAGGAGATCAGGGCGACCTGCACGCACTGCGTAGAGCCTGGAAGGGAAGTGAGAAACCA GCCGACCGGCCCTGCCCCTCTTCCCGGGATCACTTAATGAACCACGTGTTTTGACATCATGTAAACCTAAGCACGTAGAGATGATTCGGA TTTGACAAAATAACATTTGAGTATCCGATTCGCCATCACCCCCTACCCCAGAAATAGGACAATTCACTTCATTGACCAAGATGATCACAT GGAAGGCGGCACAGAGGCAGCTGTGTGGGCTGCAGATTTCCTGTGTGGGGTTCAGCGTAGAAAACGCACCTCCATCCCGCCCTTCCCACA GCATTCCTCCATCTTAGATAGATGGTACTCTCCAAAGGCCCTACCAGAGGGAACACGGCCTACTGAGCGGACAGAATGATGCCAAAATAT TGCTTATGTCTCTACATGGTATTGTAATGAATATCTGCTTTAATATAGCTATCATTTCTTTTCCAAAATTACTTCTCTCTATCTGGAATT TAATTAATCGAAATGAATTTATCTGAATATAGGAAGCATATGCCTACTTGTAATTTCTAACTCCTTATGTTTGAAGAGAAACCTCCGGTG >In-frame_ENST00000452146_ENST00000389413_TCGA-X6-A8C4-01A_GALNT11_chr7_151722969_+_PTPRN2_chr7_158282477_length(amino acids)=991AA_start in transcript=7_stop in transcript=2982 MAAGPRGSSARAAPAGRTGAVAGEKMPQPESQKAAILGCGQGGCLLEEGLCGASEACVNDGVFGRCQKVPAMDFYRYEVSPVALQRLRVA LQKLSGTGFTWQDDYTQYVMDQELADLPKTYLRRPEASSPARPSKHSVGSERRYSREGGAALANALRRHLPFLEALSQAPASDVLARTHT AQDRPPAEGDDRFSESILTYVAHTSALTYPPGSRTQLREDLLPRTLGQLQPDELSPKVDSGVDRHHLMAALSAYAAQRPPAPPGEGSLEP QYLLRAPSRMPRPLLAPAAPQKWPSPLGDSEDPSSTGDGARIHTLLKDLQRQPAEVRGLSGLELDGMAELMAGLMQGVDHGVARGSPGRA ALGESGEQADGPKATLRGDSFPDDGVQDDDDRLYQEVHRLSATLGGLLQDHGSRLLPGALPFARPLDMERKKSEHPESSLSSEEETAGVE NVKSQTYSKDLLGQQPHSEPGAAAFGELQNQMPGPSKEEQSLPAGAQEALSDGLQLEVQPSEEEARGYIVTDREVLGPAVTFKVSANVQN VTTEDVEKATVDNKDKLEETSGLKILQTGVGSKSKLKFLPPQAEQEDSTKFIALTLVSLACILGVLLASGLIYCLRHSSQHRLKEKLSGL GGDPGADATAAYQELCRQRMATRPPDRPEGPHTSRISSVSSQFSDGPIPSPSARSSASSWSEEPVQSNMDISTGHMILSYMEDHLKNKNR LEKEWEALCAYQAEPNSSFVAQREENVPKNRSLAVLTYDHSRVLLKAENSHSHSDYINASPIMDHDPRNPAYIATQGPLPATVADFWQMV WESGCVVIVMLTPLAENGVRQCYHYWPDEGSNLYHIYEVNLVSEHIWCEDFLVRSFYLKNLQTNETRTVTQFHFLSWYDRGVPSSSRSLL DFRRKVNKCYRGRSCPIIVHCSDGAGRSGTYVLIDMVLNKMAKGAKEIDIAATLEHLRDQRPGMVQTKEQFEFALTAVAEEVNAILKALP -------------------------------------------------------------- >In-frame_ENST00000452146_ENST00000409483_TCGA-X6-A8C4-01A_GALNT11_chr7_151722969_+_PTPRN2_chr7_158282477_length(transcript)=4614nt_BP=134nt GCGACGCCTGGCTGCTGGGCCCCGGGGCAGTTCAGCCCGCGCCGCTCCTGCGGGTCGGACTGGGGCTGTGGCGGGAGAGAAGATGCCGCA GCCCGAGTCCCAGAAGGCGGCGATCCTGGGCTGCGGGCAAGGCGGCTGCCTGCTCGAGGAGGGCCTCTGCGGAGCGTCCGAGGCCTGTGT GAACGGTTTCACGTGGCAGGATGACTATACTCAGTATGTGATGGACCAGGAACTTGCAGACCTCCCGAAAACCTACCTGAGGCGTCCTGA AGCATCCAGCCCAGCCAGGCCCTCAAAACACAGCGTTGGCAGCGAGAGGAGGTACAGTCGGGAGGGCGGTGCTGCCCTGGCCAACGCCCT CCGACGCCACCTGCCCTTCCTGGAGGCCCTGTCCCAGGCCCCAGCCTCAGACGTGCTCGCCAGGACCCATACGGCGCAGGACAGACCCCC CGCTGAGGGTGATGACCGCTTCTCCGAGAGCATCCTGACCTATGTGGCCCACACGTCTGCGCTGACCTACCCTCCCGGGTCCCGGACCCA GCTCCGCGAGGACCTCCTGCCGCGGACCCTCGGCCAGCTCCAGCCAGATGAGCTCAGCCCTAAGGTGGACAGTGGTGTGGACAGACACCA TCTGATGGCGGCCCTCAGTGCCTATGCTGCCCAGAGGCCCCCAGCTCCCCCCGGGGAGGGCAGCCTGGAGCCACAGTACCTTCTGCGTGC ACCCTCAAGAATGCCCAGGCCTTTGCTGGCACCAGCCGCCCCCCAGAAGTGGCCTTCACCTCTGGGAGATTCCGAAGACCCCTCCAGCAC AGGCGATGGAGCACGGATTCATACCCTCCTGAAGGACCTGCAGAGGCAGCCGGCTGAGGTGAGGGGCCTGAGTGGCCTGGAGCTGGACGG CATGGCTGAGCTGATGGCTGGCCTGATGCAAGGCGTGGACCATGGAGTAGCTCGAGGCAGCCCTGGGAGAGCGGCCCTGGGAGAGTCTGG AGAACAGGCGGATGGCCCCAAGGCCACCCTCCGTGGAGACAGCTTTCCAGATGACGGAGTGCAGGACGACGATGATAGACTTTACCAAGA GGTCCATCGTCTGAGTGCCACACTCGGGGGCCTCCTGCAGGACCACGGGTCTCGACTCTTACCTGGAGCCCTCCCCTTTGCAAGGCCCCT CGACATGGAGAGGAAGAAGTCCGAGCACCCTGAGTCTTCCCTGTCTTCAGAAGAGGAGACTGCCGGAGTGGAGAACGTCAAGAGCCAGAC GTATTCCAAAGATCTGCTGGGGCAGCAGCCGCATTCGGAGCCCGGGGCCGCTGCGTTTGGGGAGCTCCAAAACCAGATGCCTGGGCCCTC GAAGGAGGAGCAGAGCCTTCCAGCGGGTGCTCAGGAGGCCCTCAGCGACGGCCTGCAATTGGAGGTCCAGCCTTCCGAGGAAGAGGCGCG GGGCTACATCGTGACAGACAGAGACCCCCTGCGCCCCGAGGAAGGAAGGCGGCTGGTGGAGGACGTCGCCCGCCTCCTGCAGGTGCCCAG CAGTGCGTTCGCTGACGTGGAGGTTCTCGGACCAGCAGTGACCTTCAAAGTGAGCGCCAATGTCCAAAACGTGACCACTGAGGATGTGGA GAAGGCCACAGTTGACAACAAAGACAAACTGGAGGAAACCTCTGGACTGAAAATTCTTCAAACCGGAGTCGGGTCGAAAAGCAAACTCAA GTTCCTGCCTCCTCAGGCGGAGCAAGAAGACTCCACCAAGTTCATCGCGCTCACCCTGGTCTCCCTCGCCTGCATCCTGGGCGTCCTCCT GGCCTCTGGCCTCATCTACTGCCTCCGCCATAGCTCTCAGCACAGGCTGAAGGAGAAGCTCTCGGGACTAGGGGGCGACCCAGGTGCAGA TGCCACTGCCGCCTACCAGGAGCTGTGCCGCCAGCGTATGGCCACGCGGCCACCAGACCGACCTGAGGGCCCGCACACGTCACGCATCAG CAGCGTCTCATCCCAGTTCAGCGACGGGCCGATCCCCAGCCCCTCCGCACGCAGCAGCGCCTCATCCTGGTCCGAGGAGCCTGTGCAGTC CAACATGGACATCTCCACCGGCCACATGATCCTGTCCTACATGGAGGACCACCTGAAGAACAAGAACCGGCTGGAGAAGGAGTGGGAAGC GCTGTGCGCCTACCAGGCGGAGCCCAACAGCTCGTTCGTGGCCCAGAGGGAGGAGAACGTGCCCAAGAACCGCTCCCTGGCCGTGCTGAC CTATGACCACTCCCGGGTCCTGCTGAAGGCGGAGAACAGCCACAGCCACTCAGACTACATCAACGCTAGCCCCATCATGGATCACGACCC GAGGAACCCCGCGTACATCGCCACCCAGGGACCGCTGCCCGCCACCGTGGCTGACTTTTGGCAGATGGTGTGGGAGAGCGGCTGCGTGGT GATCGTCATGCTGACACCCCTCGCGGAGAACGGCGTCCGGCAGTGCTACCACTACTGGCCGGATGAAGGCTCCAATCTCTACCACATCTA TGAGGTGAACCTGGTCTCCGAGCACATCTGGTGTGAGGACTTCCTGGTGAGGAGCTTCTATCTGAAGAACCTGCAGACCAACGAGACGCG CACCGTGACGCAGTTCCACTTCCTGAGTTGGTATGACCGAGGAGTCCCTTCCTCCTCAAGGTCCCTCCTGGACTTCCGCAGAAAAGTAAA CAAGTGCTACAGGGGCCGTTCTTGTCCAATAATTGTTCATTGCAGTGACGGTGCAGGCCGGAGCGGCACCTACGTCCTGATCGACATGGT TCTCAACAAGATGGCCAAAGGTGCTAAAGAGATTGATATCGCAGCGACCCTGGAGCACTTGAGGGACCAGAGACCCGGCATGGTCCAGAC GAAGGAGCAGTTTGAGTTCGCGCTGACAGCCGTGGCTGAGGAGGTGAACGCCATCCTCAAGGCCCTTCCCCAGTGAGCGGCAGCCTCAGG GGCCTCAGGGGAGCCCCCACCCCACGGATGTTGTCAGGAATCATGATCTGACTTTAATTGTGTGTCTTCTATTATAACTGCATAGTAATA GGGCCCTTAGCTCTCCCGTAGTCAGCGCAGTTTAGCAGTTAAAAGTGTATTTTTGTTTAATCAAACAATAATAAAGAGAGATTTGTGGAA AAATCCAGTTACGGGTGGAGGGGAATCGGTTCATCAATTTTCACTTGCTTAAAAAAAATACTTTTTCTTAAAGCACCCGTTCACCTTCTT GGTTGAAGTTGTGTTAACAATGCAGTAGCCAGCACGTTCGAGGCGGTTTCCAGGAAGAGTGTGCTTGTCATCTGCCACTTTCGGGAGGGT GGATCCACTGTGCAGGAGTGGCCGGGGAAGCTGGCAGCACTCAGTGAGGCCGCCCGGCACACAAGGCACGTTTGGCATTTCTCTTTGAGA GAGTTTATCATTGGGAGAAGCCGCAGGGACAGAACTGAACGTCCTGCAGCTTCGGGGCAAGTGAGACAATCACAGCTCCTCGCTGCGTCT CCATCAACACTGCGCCGGGTACCATGGACGGCCCCGTCAGCCACACCTGTCAGCCCAAGCAGAGTGATTCAGGGGCTCCCCGGGGGCAGA CACCTGTGCACCCCATGAGTAGTGCCCACTTGAGGCTGGCACTCCCCTGACCTCACCTTTGCAAAGTTACAGATGCACCCCAACATTGAG ATGTGTTTTTAATGTTAAAATATTGATTTCTACGTTATGAAAACAGATGCCCCCGTGAATGCTTACCTGTGAGATAACCACAACCAGGAA GAACAAATCTGGGCATTGAGCAAGCTATGAGGGTCCCCGGGAGCACACGAACCCTGCCAGGCCCCCGCTGGCTCCTCCAGGCACGTCCCG GACCTGTGGGGCCCCAGAGAGGGGACATTTCCCTCCTGGGAGAGAAGGAGATCAGGGCAACTCGGAGAGGGCTGCGAGCATTTCCCTCCC GGGAGAGGAGATCAGGGCGACCTGCACGCACTGCGTAGAGCCTGGAAGGGAAGTGAGAAACCAGCCGACCGGCCCTGCCCCTCTTCCCGG GATCACTTAATGAACCACGTGTTTTGACATCATGTAAACCTAAGCACGTAGAGATGATTCGGATTTGACAAAATAACATTTGAGTATCCG ATTCGCCATCACCCCCTACCCCAGAAATAGGACAATTCACTTCATTGACCAAGATGATCACATGGAAGGCGGCACAGAGGCAGCTGTGTG GGCTGCAGATTTCCTGTGTGGGGTTCAGCGTAGAAAACGCACCTCCATCCCGCCCTTCCCACAGCATTCCTCCATCTTAGATAGATGGTA CTCTCCAAAGGCCCTACCAGAGGGAACACGGCCTACTGAGCGGACAGAATGATGCCAAAATATTGCTTATGTCTCTACATGGTATTGTAA TGAATATCTGCTTTAATATAGCTATCATTTCTTTTCCAAAATTACTTCTCTCTATCTGGAATTTAATTAATCGAAATGAATTTATCTGAA TATAGGAAGCATATGCCTACTTGTAATTTCTAACTCCTTATGTTTGAAGAGAAACCTCCGGTGTGAGATATACAAATATATTTAATTGTG >In-frame_ENST00000452146_ENST00000409483_TCGA-X6-A8C4-01A_GALNT11_chr7_151722969_+_PTPRN2_chr7_158282477_length(amino acids)=982AA_start in transcript=7_stop in transcript=2955 MAAGPRGSSARAAPAGRTGAVAGEKMPQPESQKAAILGCGQGGCLLEEGLCGASEACVNGFTWQDDYTQYVMDQELADLPKTYLRRPEAS SPARPSKHSVGSERRYSREGGAALANALRRHLPFLEALSQAPASDVLARTHTAQDRPPAEGDDRFSESILTYVAHTSALTYPPGSRTQLR EDLLPRTLGQLQPDELSPKVDSGVDRHHLMAALSAYAAQRPPAPPGEGSLEPQYLLRAPSRMPRPLLAPAAPQKWPSPLGDSEDPSSTGD GARIHTLLKDLQRQPAEVRGLSGLELDGMAELMAGLMQGVDHGVARGSPGRAALGESGEQADGPKATLRGDSFPDDGVQDDDDRLYQEVH RLSATLGGLLQDHGSRLLPGALPFARPLDMERKKSEHPESSLSSEEETAGVENVKSQTYSKDLLGQQPHSEPGAAAFGELQNQMPGPSKE EQSLPAGAQEALSDGLQLEVQPSEEEARGYIVTDRDPLRPEEGRRLVEDVARLLQVPSSAFADVEVLGPAVTFKVSANVQNVTTEDVEKA TVDNKDKLEETSGLKILQTGVGSKSKLKFLPPQAEQEDSTKFIALTLVSLACILGVLLASGLIYCLRHSSQHRLKEKLSGLGGDPGADAT AAYQELCRQRMATRPPDRPEGPHTSRISSVSSQFSDGPIPSPSARSSASSWSEEPVQSNMDISTGHMILSYMEDHLKNKNRLEKEWEALC AYQAEPNSSFVAQREENVPKNRSLAVLTYDHSRVLLKAENSHSHSDYINASPIMDHDPRNPAYIATQGPLPATVADFWQMVWESGCVVIV MLTPLAENGVRQCYHYWPDEGSNLYHIYEVNLVSEHIWCEDFLVRSFYLKNLQTNETRTVTQFHFLSWYDRGVPSSSRSLLDFRRKVNKC -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for GALNT11-PTPRN2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GALNT11-PTPRN2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for GALNT11-PTPRN2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |